Showing results (1471-1480 of 1,504) with videos related to

Sort By:
Pageof 151
Nature Nanotechnology|February 3, 2025
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitorsStijn R J Hofstraat, Tom Anbergen, Robby Zwolsman, et al.
Nature Nanotechnology|July 31, 2024
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapyAnnelies C Wauters, Jari F Scheerstra, Mandy M T van Leent, et al.
Frontiers in Immunology|November 15, 2023
Mediport use as an acceptable standard for CAR T cell infusionMaya Eylon, Snehit Prabhu, Samuel John, et al.
Science Advances|January 1, 2026
Systemically inducing trained immunity overcomes solid tumors' immunosuppressive microenvironmentBram Priem, Lisa Willemsen, Tom Anbergen, et al.
Nature Biotechnology|June 8, 2017
The promise of organ and tissue preservation to transform medicineSebastian Giwa, Jedediah K Lewis, Luis Alvarez, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 26, 2022
Clinical validity assessment of genes frequently tested on intellectual disability/autism sequencing panelsErin Rooney Riggs, Taylor I Bingaman, Carrie-Ann Barry, et al.
Genome Announcements|June 20, 2015
Genome Sequences of Mycobacteriophages AlanGrant, Baee, Corofin, OrangeOswald, and Vincenzo, New Members of Cluster BWelkin H Pope, Maria E Carbonara, Hanna M Cioffi, et al.
Nature Cancer|February 28, 2022
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncologyKatrin P Guillen, Maihi Fujita, Andrew J Butterfield, et al.
Iscience|April 3, 2025
Targeting mTOR in myeloid cells prevents infection-associated inflammationYohana C Toner, Jazz Munitz, Geoffrey Prevot, et al.
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|December 19, 2012
Medical planning and response for a nuclear detonation: a practical guideC Norman Coleman, Steven Adams, Carl Adrianopoli, et al.
Pageof 151